216 related articles for article (PubMed ID: 23621869)
1. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
Wang L; Meng Q; Wang C; Liu Q; Peng J; Huo X; Sun H; Ma X; Liu K
J Nat Prod; 2013 May; 76(5):909-14. PubMed ID: 23621869
[TBL] [Abstract][Full Text] [Related]
2. Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1.
Wang C; Huo X; Wang L; Meng Q; Liu Z; Liu Q; Sun H; Sun P; Peng J; Liu K
Sci Rep; 2016 Jun; 6():28403. PubMed ID: 27329817
[TBL] [Abstract][Full Text] [Related]
3. Dioscin enhances methotrexate absorption by down-regulating MDR1 in vitro and in vivo.
Wang L; Wang C; Peng J; Liu Q; Meng Q; Sun H; Huo X; Sun P; Yang X; Zhen Y; Liu K
Toxicol Appl Pharmacol; 2014 Jun; 277(2):146-54. PubMed ID: 24680847
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
[TBL] [Abstract][Full Text] [Related]
5. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
Sun BT; Zheng LH; Bao YL; Yu CL; Wu Y; Meng XY; Li YX
Eur J Pharmacol; 2011 Mar; 654(2):129-34. PubMed ID: 21195709
[TBL] [Abstract][Full Text] [Related]
6. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
[TBL] [Abstract][Full Text] [Related]
7. [NF-kappaB regulating expression of mdr1 gene and P-gp to reverse drug-resistance in leukemic cells].
Wang Y; Liu X; Zhang HT; Yu M; Wang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):950-4. PubMed ID: 17956668
[TBL] [Abstract][Full Text] [Related]
8. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
9. Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.
Kim HG; Hien TT; Han EH; Hwang YP; Choi JH; Kang KW; Kwon KI; Kim BH; Kim SK; Song GY; Jeong TC; Jeong HG
Br J Pharmacol; 2011 Mar; 162(5):1096-108. PubMed ID: 21054339
[TBL] [Abstract][Full Text] [Related]
10. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
[TBL] [Abstract][Full Text] [Related]
11. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
[TBL] [Abstract][Full Text] [Related]
12. [Reversal effect of nuclear factor-κB protease inhibitor PDTC on multidrug resistance of K562/AO₂ cells and its mechanism].
Yang TT; Xue TY; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):903-8. PubMed ID: 20723297
[TBL] [Abstract][Full Text] [Related]
13. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y
Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986
[TBL] [Abstract][Full Text] [Related]
14. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
Tran TP; Kim HG; Choi JH; Na MK; Jeong HG
Phytomedicine; 2013 May; 20(7):622-31. PubMed ID: 23466342
[TBL] [Abstract][Full Text] [Related]
15. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
16. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
Pan J; Miao D; Chen L
Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
[TBL] [Abstract][Full Text] [Related]
17. [Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
Han YQ; Yuan JY; Shi YJ; Zhu Y; Wu SL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):604-8. PubMed ID: 14706144
[TBL] [Abstract][Full Text] [Related]
18. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
[TBL] [Abstract][Full Text] [Related]
19. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
[TBL] [Abstract][Full Text] [Related]
20. [Reversal effect of sodium selenite on multidrug resistance in K562/ADR cell line and its mechanisms].
Cui J; Ding J; Wu YP; Liu FQ; Liu XC; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):756-61. PubMed ID: 17708798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
